Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eisen, A.
Right arrow Articles by Gibson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisen, A.
Right arrow Articles by Gibson, G.
NEUROLOGY 1983;33:1109
© 1983 American Academy of Neurology

Inclusion body myositis (IBM)

Myopathy or neuropathy?

Andrew Eisen, MD, Kenneth Berry, MD and Gillian Gibson, MD

Divisions of Neurology and Neuropathology, the Vancouver General Hospital and The University of British Columbia, Vancouver, Canada.

Inclusion body myositis (IBM) is described in six elderly patients (three women) and in a young familial patient. They all showed the morphologically characteristic vacuoles containing osmiophilic membranous whorls and intracvtodasmic or intranuclear inclusions. There is a well-delineated bimodal age spectrum of IBM, with onset in the second and sixth decades, but otherwise the disorder seems to be a specific entky. Clinical, electrophysiologic, and morphologic features suggest a neurogenic origin in some cases.

Address correspondence and reprint requests to Dr. Eisen, Department of Diagnostic Neurophysiolugy (EMG), Vancouver General Hospital, 855 West 12th Avenue, Vancouver, Canada V5Z 1M9.

Presented in part at the Fifth International Congress on Neuromuscular Disease, Marseilles, France, September 12–18, 1982.

Accepted for publication January 28, 1983.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
R. Dabby, D. J. Lange, W. Trojaborg, A. P. Hays, R. E. Lovelace, T. H. Brannagan, and L. P. Rowland
Inclusion Body Myositis Mimicking Motor Neuron Disease
Arch Neurol, August 1, 2001; 58(8): 1253 - 1256.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L.-W. Jin, M. G. Hearn, C. E. Ogburn, N. Dang, D. Nochlin, W. C. Ladiges, and G. M. Martin
Transgenic Mice Over-Expressing the C-99 Fragment of ßPP with an {alpha}-Secretase Site Mutation Develop a Myopathy Similar to Human Inclusion Body Myositis
Am. J. Pathol., December 1, 1998; 153(6): 1679 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
T. H Brannagan, A. P Hays, D. J Lange, and W. Trojaborg
The role of quantitative electromyography in inclusion body myositis
J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 776 - 779.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.